Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1208-1209 (31 May), doi:10.1136/bmj.39591.450856.DB
Michael Day
1 Milan
The first 150 words of the full text of this article appear below. |
A scandal involving drug licences for cash has engulfed Italys drug regulatory agency, and leading officials have been arrested, along with people linked to major drug companies.
The most senior figure to have been arrested and held by the police in his own home ("arresto al domiciliaro") is Pasqualino Rossi, vice president of the Agenzia Italiana del Farmaco (AIFA), the Italian Agency for Pharmaceuticals. Dr Rossi is also one of Italys most senior representatives at the European Medicines Agency (EMEA).
Six drug company lobbyists have also been held. As the BMJ went to press, four people were in custody and three were under house arrest. Another individual wanted by the police was not in Italy.
Arrest warrants were issued after a Turin investigating judge, Sandra Recchione, saw a 700 page police report concerning alleged falsification, in return for cash payments, of clinical data needed for drug licences.
At the centre
CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+